News

Without Updated Tools, NFL still finding Concussions too late

Oculogica Founder Dr. Uzma Samadani is featured in a story Elena Bergeron at the NY Times. Clickhere to read the full article. Concussions can cause much subtler symptoms, including headaches, sluggishnessand difficulty sleeping, some of which are not present immediately after a trauma.The absence of obvious symptoms makes the type of instant diagnosis that is […]

Without Updated Tools, NFL still finding Concussions too late Read More »

Sisters get Concussion Diagnostic funded, FDA approved and reimbursed

CEO Rosina Samadani is featured in a story by Geri Stengel at Forbes. Click here to read the fullarticle. Two sisters teamed up to develop and bring to market an EyeBOX—the firstobjective diagnostic for concussions. The algorithm-based test takes less than fourminutes, is non-invasive, and can be used with children and adults. Oculogica’sEyeBOX moves beyond

Sisters get Concussion Diagnostic funded, FDA approved and reimbursed Read More »

The Packers are the only N.F.L. team whose fans can buy an ownership stake

Oculogica is featured in a story by Ken Belson at the New York Times. Click here to read. Among the offices facing Lambeau Field are those of some of the nearly two dozen tech start-ups in which the team has invested. The Packers and Microsoft each contributed $5 million to a $25 million fund to incubate emerging

The Packers are the only N.F.L. team whose fans can buy an ownership stake Read More »

Oculogica promotes Justin Johnson to Vice President of Commercial Development

Oculogica, a leader in concussion diagnostics, announces that Justin Johnson has been promoted to the role of Vice President of Commercial Development. Justin has an impressive background in business development and sales management spanning 20 years. Highlighted by various roles at organizations such as Smith & Nephew, Biomet Orthopaedics, and Millennium Medical Technologies, where his

Oculogica promotes Justin Johnson to Vice President of Commercial Development Read More »

Oculogica Partners with St. Paul-based Minnetronix Medical

March 8, 2022 — Oculogica and Minnetronix announce a partnership to manufacture EyeBOX. Parents with children in sports often worry about concussions. It’s an anxiety that we are allaying with technology. The EyeBOX can help diagnose a possible concussion in less than four minutes — 220 seconds, to be precise. Rather than trusting a patient’s

Oculogica Partners with St. Paul-based Minnetronix Medical Read More »

Oculogica Welcomes David Lorek as Senior Software Engineer

Oculogica, a leader in concussion diagnostics, today announced that David Lorek has joined the company as Senior Software Engineer.   David has over 25 years of experience in software design and developing systems in public safety, pre-clinical and clinical industries creating scalable, user-friendly solutions.  Prior to joining Oculogica, David worked in large and small companies in private

Oculogica Welcomes David Lorek as Senior Software Engineer Read More »

West High students learn latest concussion technology

West High School upperclassmen got a first-hand look at some brand new concussion technology. KNOXVILLE, Tenn. (WVLT) – West High School upperclassmen got a first-hand look at some brand new concussion technology. The technology isn’t new, but using it to treat concussions is. Students met with Dr. Todd Abel, of the Neurologic Performance Group. “We don’t want

West High students learn latest concussion technology Read More »

Oculogica Receives FDA Clearance for its Next Generation EyeBOX

Oculogica, a leader in concussion diagnostics, announced that the U.S. Food and Drug Administration (FDA) granted clearance for the Company’s next generation EyeBOX. The EyeBOX is the first objective testing device authorized by the FDA as an aid in the diagnosis of concussion. The EyeBOX performs a test in under 4-minutes, utilizing a proprietary algorithm and machine

Oculogica Receives FDA Clearance for its Next Generation EyeBOX Read More »

Scroll to Top